Suchergebnisse - "Best, Jennie H"

PubPharm (76)

41

Dynamic risk factors associated with non-severe hypoglycemia in patients treated with insulin glargine or exenatide once weekly

enthalten in: Journal of diabetes | 2015

von Paul, S. | Maggs, D. | Klein, K. | +1

42

The association of the treatment with glucagon-like peptide-1 receptor agonist exenatide or insulin with cardiovascular outcomes in patients with type 2 diabetes : a retrospective observational study

enthalten in: Cardiovascular diabetology | 2015

von Paul, S. | Klein, K. | Maggs, D. | +1

43

The association of the treatment with glucagon-like peptide-1 receptor agonist exenatide or insulin with cardiovascular outcomes in patients with type 2 diabetes: a retrospective observational study

enthalten in: Cardiovascular diabetology | 2015

von Paul, S. | Klein, K. | Maggs, D. | +1

44

The association of the treatment with glucagon-like peptide-1 receptor agonist exenatide or insulin with cardiovascular outcomes in patients with type 2 diabetes: a retrospective observational study

enthalten in: Cardiovascular diabetology | 2015

von Paul, S. | Klein, K. | Maggs, D. | +1

45

Observational study of kidney function and albuminuria in patients with type 2 diabetes treated with exenatide BID versus insulin glargine

enthalten in: The Annals of pharmacotherapy | 2014

von Pawaskar, M. | Tuttle, K. | Li, Q. | +2

46

Treatment of patients with type 2 diabetes with exenatide once weekly versus oral glucose-lowering medications or insulin glargine : achievement of glycemic and cardiovascular goals

enthalten in: Cardiovascular diabetology | 2013

von Meloni, A. | DeYoung, M. | Han, J. | +2

47

Treatment of patients with type 2 diabetes with exenatide once weekly versus oral glucose-lowering medications or insulin glargine: achievement of glycemic and cardiovascular goals

enthalten in: Cardiovascular diabetology | 2013

von Meloni, A. | DeYoung, M. | Han, J. | +2

48

Treatment of patients with type 2 diabetes with exenatide once weekly versus oral glucose-lowering medications or insulin glargine: achievement of glycemic and cardiovascular goals

enthalten in: Cardiovascular diabetology | 2013

von Meloni, A. | DeYoung, M. | Han, J. | +2

49

Development and validation of the self-management profile for type 2 diabetes (SMP-T2D)

enthalten in: Health and quality of life outcomes | 2012

von Peyrot, M. | Bushnell, D. | Best, J. | +3

50

Development and validation of the self-management profile for type 2 diabetes (SMP-T2D)

enthalten in: Health and quality of life outcomes | 2012

von Peyrot, M. | Bushnell, D. | Best, J. | +3